2018
DOI: 10.1016/j.ejps.2018.01.046
|View full text |Cite
|
Sign up to set email alerts
|

Chitosan-based nanosystems and their exploited antimicrobial activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
106
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 225 publications
(108 citation statements)
references
References 124 publications
2
106
0
Order By: Relevance
“…Chitosan is a polysaccharide formed by a randomly distributed β-(1→4)-linked D-glucosamine and N-acetyl-D-glucosamine monomers. The chitosan types differ in molecular weight, degree and pattern of N-acetylation [62]. They are obtained by the process of alkaline deacetylation of chitin [63].…”
Section: Polymeric Nanoparticlesmentioning
confidence: 99%
See 1 more Smart Citation
“…Chitosan is a polysaccharide formed by a randomly distributed β-(1→4)-linked D-glucosamine and N-acetyl-D-glucosamine monomers. The chitosan types differ in molecular weight, degree and pattern of N-acetylation [62]. They are obtained by the process of alkaline deacetylation of chitin [63].…”
Section: Polymeric Nanoparticlesmentioning
confidence: 99%
“…The chitosan pKa is approximately 6.5, being soluble in acid medium and insoluble in alkaline and neutral media [63]. Chitosan has been investigated for use in several areas such as food, cosmetic, pharmaceutical and agrochemical industries [34,44,62,[65][66][67]. Chitosan is non-toxic, biocompatible, biodegradable [63], has antimicrobial activity, and low immunogenicity while properties like mucoadhesion, controlled drug delivery, and in situ gelation improve permeation [68].…”
Section: Polymeric Nanoparticlesmentioning
confidence: 99%
“…In recent study, chitosan shows potential anti-QS activity by disturbing biofilm formation and inhibiting C. violaceum violacein production [21]. Chitosan-based nanomaterials have also shown biological activities against microorganisms, including bacteria and fungi activity [22,23]. Recent studies have shown that the enhanced antimicrobial activity of chitosan-based NPs is related to the increase of surface area to volume ratio as the particle size decreases [63,64].…”
Section: Introductionmentioning
confidence: 99%
“…An optimal localized treatment of vaginal infections depends not only on the potency of the active ingredient/drug, but also on the physiochemical properties of the formulation; an ideal formulation can protect and enhance as well as act in synergy with antimicrobial to assure successful therapy [23]. Chitosan-based delivery systems exhibit strong mucoadhesive properties, an excellent safety profile and intrinsic antimicrobial activity of chitosan, which add to their attractiveness as pharmaceutical formulations, including those destined for vaginal delivery [4,17,24,25]. However, relatively little is known about the effects of the type of formulation on the antimicrobial performance of the formulation.…”
Section: Resultsmentioning
confidence: 99%